Increasing Cancer Research Driving Primary Cell Market
The primary cells market is expected to reach USD 1,107.3 million by 2023 from USD 736.4 million in 2018, at a CAGR of 8.5%. The rising research and funding for cancer research, benefits of primary human cells over cell lines, constant growth in the biotechnology and biopharmaceutical industries, and increasing pharmaceutical outsourcing are the major factors driving the growth of the primary cells...